🇮🇳IN
Sign In
MO

MOREPENLAB

NSE

Morepen Laboratories Ltd

₹123.54

+5.87(+4.99%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

MOREPENLAB financial summary

For Mar 2026, Morepen Laboratories Ltd reported revenue of ₹1,681 crore, which grew 8.1% from the previous year. Net profit was ₹66 crore, which fell 35.3% year on year, on an operating margin of 7%. Earnings per share came in at ₹1.21. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹1,681 crore
Net profit₹66 crore
Operating margin7%
EPS₹1.21

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer